United Therapeutics Corp UTH.DU Stock
300.9 EUR
{{ price }}
1.142855%
{{change_pct}}%
COUNTRY
Germany
Exchange
Dusseldorf
Market Cap
0 EUR
LOW - HIGH [24H]
300.9
-
300.9 EUR
VOLUME [24H]
30 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
0 EUR
United Therapeutics Corp Price Chart
United Therapeutics Corp UTH.DU Financial and Trading Overview
| United Therapeutics Corp stock price | 300.9 EUR |
| Previous Close | 209 EUR |
| Open | 207.9 EUR |
| Bid | 209.1 EUR x N/A |
| Ask | 210.8 EUR x N/A |
| Day's Range | 207.9 - 209.3 EUR |
| 52 Week Range | 189.25 - 277 EUR |
| Volume | 3 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
UTH.DU Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
United Therapeutics Corp Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 277 EUR |
| 52 Week Low | 189.25 EUR |
| 50-Day Moving Average | 201.79 EUR |
| 200-Day Moving Average | 226.93 EUR |
UTH.DU Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For United Therapeutics Corp Stock
What is a current UTH.DU stock price?
United Therapeutics Corp UTH.DU stock price today per share is 300.9 EUR.
How to purchase United Therapeutics Corp stock?
You can buy UTH.DU shares on the Dusseldorf exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for United Therapeutics Corp?
The stock symbol or ticker of United Therapeutics Corp is UTH.DU.
How many shares does United Therapeutics Corp have in circulation?
The max supply of United Therapeutics Corp shares is 0.
What is United Therapeutics Corp Price to Earnings Ratio (PE Ratio)?
United Therapeutics Corp PE Ratio is now.
What was United Therapeutics Corp earnings per share over the trailing 12 months (TTM)?
United Therapeutics Corp EPS is 0 EUR over the trailing 12 months.